These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15745085)

  • 1. Do elevated plasma vasoactive intestinal polypeptide (VIP) levels cause small intestinal motor disturbances in humans?
    Keller J; Mueller-Wolf JC; Ahmadi-Simab K; Fibbe C; Rosien U; Layer P
    Dig Dis Sci; 2005 Feb; 50(2):276-82. PubMed ID: 15745085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.
    Kane MG; O'Dorisio TM; Krejs GJ
    N Engl J Med; 1983 Dec; 309(24):1482-5. PubMed ID: 6316136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin infusion on VIP-induced transport changes in the human jejunum.
    Krejs GJ
    Peptides; 1984; 5(2):271-6. PubMed ID: 6147815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine.
    Sninsky CA; Wolfe MM; Martin JL; Howe BA; O'Dorisio TM; McGuigan JE; Mathias JR
    Am J Physiol; 1983 Jan; 244(1):G46-51. PubMed ID: 6849393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics].
    Reindl T; Degenhardt P; Luck W; Riebel T; Sarioglu N; Henze G; Driever PH
    Klin Padiatr; 2004; 216(5):264-9. PubMed ID: 15455292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VIPoma syndrome.
    Krejs GJ
    Am J Med; 1987 May; 82(5B):37-48. PubMed ID: 3035922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of VIP infusion in water and ion transport in the human jejunum.
    Krejs GJ; Fordtran JS; Fahrenkrug J; Schaffalitzky de Muckadell OB; Fischer JE; Humphrey CS; O'Dorisio TM; Said SI; Walsh JH; Shulkes AA
    Gastroenterology; 1980 Apr; 78(4):722-7. PubMed ID: 7353759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WDHA (watery diarrhea, hypokalemia, achlorhydria) syndrome: clinical features, diagnosis, and treatment.
    Grier JF
    South Med J; 1995 Jan; 88(1):22-4. PubMed ID: 7817223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
    Said SI
    World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of psychological stress on small intestinal motility and expression of cholecystokinin and vasoactive intestinal polypeptide in plasma and small intestine in mice.
    Cao SG; Wu WC; Han Z; Wang MY
    World J Gastroenterol; 2005 Feb; 11(5):737-40. PubMed ID: 15655834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vasoactive intestinal polypeptide on meal-stimulated gastric acid secretion in man.
    Holm-Bentzen M; Christiansen J; Kirkegaard P; Olsen PS; Petersen B; Fahrenkrug J
    Scand J Gastroenterol; 1983 Jul; 18(5):659-61. PubMed ID: 6675186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
    Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
    Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
    Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
    J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian coupling between pancreatic secretion and intestinal motility in humans.
    Keller J; Gröger G; Cherian L; Günther B; Layer P
    Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G273-8. PubMed ID: 11208550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of human periodic interdigestive gastrointestinal motor and pancreatic function by the ileum.
    Layer P; Schlesinger T; Gröger G; Goebell H
    Pancreas; 1993 Jul; 8(4):426-32. PubMed ID: 8361961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic diarrhea due to VIPoma in two children.
    Socha J; Dobrzańska A; Rowecka K; Cichy W; Bierła J; Stodulski J; Woźniewicz B
    J Pediatr Gastroenterol Nutr; 1984; 3(1):143-8. PubMed ID: 6319655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
    Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
    Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
    Scheibel E; Rechnitzer C; Fahrenkrug J; Hertz H
    Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome.
    Brunt LM; Mazoujian G; O'Dorisio TM; Wells SA
    Surgery; 1994 Mar; 115(3):362-9. PubMed ID: 8128360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.